In conclusion, this review summarizes current evidence on the potential contribution of the OPG-RANKL-RANK axis to the pathogenesis of metabolic diseases (obesity, T2DM, and NAFLD). The gene discussed is TNFRSF11A; the disease is type 2 diabetes mellitus.